Skip to main content
Clinical Trials/IRCT2012081410336N3
IRCT2012081410336N3Completed未知

Comparison the effects of intravenous remifentanil and dexmedtomidine in post spinal fusion surgery

Tehran University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 65 years (—)
Sex
All

Inclusion Criteria

  • 1-Patients between 15-65 years
  • 2-With American Society of anethesiologist grade I& II
  • 3-Candidated for posterior spinal fusion surgery maximally at 3 levels
  • 4-sign informed consent
  • Exclusion criteria:
  • Having heart, lung, renal and hepatic diseases, coagulopathy
  • No sign the informed consent

Exclusion Criteria

  • Not provided

Investigators

Similar Trials